Analyst Relations Strategy: How to Make Analysts Work for You

Analyst relations strategy is the planned, deliberate approach a company takes to building and managing relationships with industry analysts, so those analysts accurately represent, reference, and recommend the company in their research, advisory work, and vendor evaluations. Done well, it shapes how buyers perceive you before they ever speak to your sales team. Done poorly, it burns time and produces nothing measurable.

Most companies treat analyst relations as a PR function. That is the first mistake. Analysts are not journalists. They are trusted advisors to the buyers you are trying to reach, and the distinction matters enormously for how you approach the relationship.

Why Analyst Relations Belongs Inside Your Commercial Strategy

I have run agencies where the client’s analyst relations programme sat inside the comms team and had almost no connection to the sales or marketing function. The team would brief Gartner or Forrester twice a year, celebrate a positive mention in a report, and then move on. Nobody tracked whether those mentions influenced pipeline. Nobody knew if the sales team was even using the analyst content in conversations with prospects.

That is not analyst relations. That is analyst administration.

Analyst relations strategy, properly constructed, starts with a commercial question: which analysts do our target buyers trust, and what do those analysts currently believe about us? Everything else flows from the answer. If a Gartner analyst advising enterprise procurement teams believes your product is a niche player with limited scalability, that belief will surface in shortlist conversations you will never be part of. You will lose deals without knowing why.

The commercial stakes are high enough that working with a specialist analyst relations agency is often the right call, particularly for companies entering new markets or defending positioning in competitive evaluations. The expertise required to handle Gartner, Forrester, IDC, and sector-specific firms simultaneously is not something most in-house teams carry at sufficient depth.

This article is part of a broader series on content strategy at The Marketing Juice, where I cover how content, editorial, and communications functions connect to commercial outcomes.

Which Analysts Actually Matter for Your Business?

The analyst landscape is vast and uneven. Gartner and Forrester dominate enterprise technology. IDC has strong reach in infrastructure and data. But outside of those three, the picture fragments quickly. There are sector-specific firms, regional firms, and boutique advisory practices that carry disproportionate influence in particular verticals.

The starting point is not a list of prestigious names. It is a question: which analysts are your buyers actually reading and quoting? That requires direct intelligence, from win/loss interviews, from sales debriefs, from conversations with customers about how they made their shortlist decisions.

When I was managing agency relationships across 30 industries, the variation in analyst influence was striking. In financial services technology, a handful of Celent and Aite-Novarica analysts carried enormous weight. In healthcare and life sciences, the dynamics were completely different. Sector-specific advisory firms and clinical technology bodies shaped buyer perception in ways that a generic enterprise analyst programme would miss entirely. If you are building content and positioning for regulated health sectors, the approach described in our work on life science content marketing applies directly here: specialist audiences require specialist credibility chains, and that includes the analysts who serve them.

Once you have identified the analysts who genuinely influence your buyers, tier them. Not every analyst relationship requires the same investment. Tier one analysts get proactive, regular engagement. Tier two get briefings when you have something genuinely significant to share. Tier three are monitored but not actively cultivated unless something changes.

What a Productive Analyst Briefing Actually Looks Like

Most analyst briefings are product demonstrations with a slide deck attached. They cover features, roadmap, customer logos, and market positioning in that order. They are, almost without exception, forgettable.

Analysts sit through hundreds of these. What they remember are the briefings where a company had a clear point of view about the market, could articulate why that view was correct, and could back it with evidence that was not just their own marketing material.

A productive briefing has a narrative structure. It opens with a market observation the analyst will find credible and possibly surprising. It then positions your company’s approach as a logical response to that observation. It uses customer evidence selectively and specifically, not as a logo parade. And it ends with a question that invites the analyst’s perspective, because the best briefings are conversations, not presentations.

Preparation matters more than most companies realise. Before a briefing, read everything the analyst has published recently. Understand their current thesis on your market. Know where you agree, where you diverge, and where you can offer data or perspective they do not have. Going into a Gartner briefing without having read the analyst’s recent research is the equivalent of pitching a journalist without having read their recent work. It shows, and it costs you credibility immediately.

The Content Marketing Institute’s framework for content strategy makes a point that applies equally here: the most effective content is built around a clear audience understanding, not around what you want to say. Analyst briefings are content. The audience is a single, very well-informed person who has heard your competitors make similar claims this week. Act accordingly.

How to Build an Analyst Relations Calendar That Connects to Revenue

Reactive analyst relations, briefing when you have a product launch, engaging when an evaluation is announced, is a losing strategy. By the time a formal evaluation is underway, analyst opinion is largely formed. You are lobbying at the last minute for a position that was decided months earlier.

An effective analyst relations calendar maps to three things: your product and commercial milestones, the analyst firm’s research and evaluation cycles, and the broader market narrative you are trying to establish over time.

Gartner Magic Quadrant submissions, Forrester Wave evaluations, and IDC MarketScape assessments all have known timelines. If you are in a category that gets evaluated, you should know those timelines twelve months in advance and be building analyst familiarity with your positioning throughout the year, not in the submission window.

Quarterly touchpoints with tier one analysts are a minimum. These do not all need to be formal briefings. A short note sharing a market data point you think they will find useful, a response to something they have published, a customer story that illustrates a trend they have been tracking. The goal is to be a useful, credible source they think of when they are forming opinions about your category.

For SaaS companies in particular, the analyst relations calendar should connect directly to the content audit cycle. If you are running a regular content audit for SaaS, that audit should surface the topics where analyst coverage intersects with your owned content gaps. Those gaps represent positioning risks: places where an analyst’s view of your category is not being reinforced by your own published perspective.

The Measurement Problem in Analyst Relations

Analyst relations is notoriously difficult to measure, and the industry has responded to that difficulty in two unhelpful ways. Some teams measure activity: number of briefings held, number of reports mentioning the company, number of analyst inquiries handled. Others claim the function is inherently unmeasurable and resist accountability entirely.

Neither position is defensible if you are spending meaningful budget on the function.

I have spent enough time looking at attribution models to be sceptical of clean causal claims in any channel. Analytics tools, whether GA4, Adobe, or something else, give you a perspective on reality, not reality itself. The same is true of analyst relations measurement. You are not going to get a clean number that says “this briefing influenced X deals worth Y revenue.” What you can do is build a measurement framework that is honest about what it is approximating.

Useful signals include: mentions in analyst research and their directional movement over time, placement in formal evaluations and quadrant position changes, analyst inquiry volume from your target accounts (if your firm has a subscription that tracks this), and sales team feedback on how often analyst content is surfacing in buyer conversations. The CMI measurement framework offers a useful structure for thinking about leading and lagging indicators that applies well here.

None of these signals is perfect. Together, they give you a directional read on whether your analyst relations programme is building the right kind of market perception. That is enough to make investment decisions, if you resist the temptation to demand false precision from inherently approximate data.

Sector-Specific Analyst Relations: Why the Generic Playbook Fails

The enterprise technology playbook for analyst relations, heavy investment in Gartner and Forrester, annual Magic Quadrant preparation, senior executive briefings, does not translate cleanly into every sector. In regulated, specialist, or public sector markets, the analyst landscape and the buyer behaviour around it are fundamentally different.

In healthcare, particularly in specialties like women’s health and reproductive medicine, the credibility infrastructure that shapes buyer decisions is built around clinical evidence, specialty society guidance, and peer networks rather than commercial analyst firms. If you are marketing technology or services into those markets, as explored in our work on Ob Gyn content marketing, the equivalent of analyst relations is engagement with clinical thought leaders, specialty boards, and the evidence networks that clinicians trust. The principle is the same: understand who your buyers trust, and build credibility with those people. The execution is entirely different.

Government technology markets present a similar challenge. Procurement in the public sector is shaped by frameworks, approved supplier lists, and policy advisory bodies that have no direct equivalent in commercial enterprise markets. For companies operating in government technology, the analyst relations strategy needs to account for those structures. Our work on B2G content marketing covers the broader content dimension of this, but the analyst relations implication is clear: know your buyer’s credibility infrastructure before you build your engagement plan.

Life sciences and pharmaceutical markets add another layer of complexity. Regulatory bodies, clinical advisory boards, and specialist health economics analysts all play roles that commercial analyst firms do not. Companies building positioning in those markets need a different engagement map entirely. The approach outlined in content marketing for life sciences addresses the broader content dimension, but analyst and thought leader engagement sits at the centre of how credibility is built in that sector.

Wistia’s research on niche audience content strategy makes a point worth applying here: the narrower and more specialist your audience, the more precisely you need to understand where they go for trusted information. That applies to analyst selection just as much as it applies to content channel selection.

What Most Companies Get Wrong About Analyst Relations

After two decades of watching marketing functions operate across industries, the consistent failures in analyst relations follow predictable patterns.

The first is treating analysts as media. Analysts are not looking for news. They are building models of how markets work and who the credible players are. Your job is to contribute to that model, not to generate coverage.

The second is sending the wrong people to briefings. Analyst relations briefings should involve people who can have a genuine intellectual conversation about the market. That often means product leadership or senior commercial people, not the communications team managing the logistics. I have seen briefings derailed because the company representative could not answer a pointed question about competitive differentiation without reading from a slide. Analysts notice. It affects their perception of the company’s depth.

The third is inconsistency. Companies engage heavily when they want something, a positive evaluation placement, a quote for a press release, and then go quiet. Analysts are not transactional relationships. The companies that perform consistently well in evaluations are the ones that have maintained a genuine ongoing dialogue, not the ones that appear every eighteen months with a briefing request.

The fourth is conflating analyst relations with analyst marketing. Buying an analyst firm’s marketing services, sponsored research, webinar slots, and the like, is a separate activity from building genuine analyst relations. It is not without value, but it does not substitute for earned credibility. Analysts distinguish between companies that have paid for visibility and companies they genuinely respect as market participants. So do sophisticated buyers.

Semrush’s work on AI-driven content strategy raises a broader point about content credibility that applies here: in markets where buyers are increasingly sophisticated about how information is produced and distributed, the source of credibility matters as much as the content itself. Analyst endorsement carries weight precisely because it is not paid placement. Protect that distinction.

Building Internal Alignment Around Analyst Relations

Analyst relations programmes fail not just because of poor external execution but because of poor internal alignment. The function sits somewhere between marketing, communications, and product, and in many organisations it belongs clearly to none of them. That ambiguity produces the worst outcome: a function with budget but no clear commercial mandate.

The analyst relations function needs a clear owner with a commercial brief. That brief should specify which markets and buyer segments the programme is designed to influence, which analyst firms and specific analysts are the priority, and what commercial outcomes the programme is expected to support over a twelve-month horizon.

Sales enablement is an underused output of analyst relations. When a company achieves a strong placement in a Gartner Magic Quadrant or a Forrester Wave, that asset should be in every relevant sales conversation within days. When an analyst publishes research that validates your market thesis, your sales team should know about it and know how to use it. The gap between analyst relations and sales enablement is one of the most consistent wastes I have seen in marketing functions. You earn credibility with analysts and then fail to use it where it matters most.

Product teams also need to be in the loop. Analyst feedback is some of the highest-quality market intelligence available. Analysts talk to your buyers, your competitors’ buyers, and your competitors. The observations they share in briefings and inquiry calls are worth more than most primary research programmes. Companies that route analyst feedback into product planning get a compounding advantage over time.

The omnichannel content strategy framework from Mailchimp is a useful lens here: the value of any content or communications investment compounds when it is connected across functions rather than siloed. Analyst relations is no different. Its output, credibility, intelligence, and validation, should flow through the whole organisation, not sit in a quarterly report that nobody reads.

If you want to see how analyst relations fits into a broader content and editorial strategy, the full picture is covered across the content strategy hub at The Marketing Juice, where I connect these individual functions to commercial outcomes rather than treating them as isolated disciplines.

About the Author

Keith Lacy is a marketing strategist and former agency CEO with 20+ years of experience across agency leadership, performance marketing, and commercial strategy. He writes The Marketing Juice to cut through the noise and share what works.

Frequently Asked Questions